Patents by Inventor Matthew Perry

Matthew Perry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8255494
    Abstract: According to one general aspect, a method of executing a web application installed on an apparatus may include executing, via a processor included by the apparatus, a web browser. The method may include loading, via the web browser, the web application. In some embodiments, the web application may include a manifest and at least a portion of a web site and wherein the web application was packaged as an installable entity. The method may further include managing, by the web browser, the execution of the web application. The method may include accessing, via the web browser, from a local storage medium one or more portions of the web site included by the web application. In some embodiments, the one or more portions of the web site may have been stored in the local storage medium when the web application was installed.
    Type: Grant
    Filed: September 27, 2011
    Date of Patent: August 28, 2012
    Assignee: Google Inc.
    Inventors: Aaron Boodman, Erik Kay, Rafael Weinstein, Matthew Perry, Glen Murphy
  • Publication number: 20120150922
    Abstract: A method and apparatus for introducing domain-specific data types with associated semantics in an RDF database system using an extensibility framework mechanism. The extensibility framework mechanism allows users to map serialized instance data for a particular user-defined data type to properties of a base data structure associated with the domain-specific data and to map instance data in base data structures to the data's serialized form. The RDF database system may return inferred properties of RDF data stored in domain-specific data types in response to a query on the data. Further, the RDF database system may infer relationships between resources in stored data.
    Type: Application
    Filed: December 13, 2010
    Publication date: June 14, 2012
    Inventors: Aravind Yalamanchi, Matthew Perry
  • Patent number: 8200962
    Abstract: According to one general aspect, a method of managing a web browser extension by an apparatus may include executing, by a processor included by the apparatus, a web browser. The method may include installing on the apparatus, via the web browser, a web browser extension. In one embodiment, the web browser extension may include at least one web page configured to alter the functionality of the web browser, and a substantially unique identifier (UID) based upon a public encryption key. The method may further include launching, via the web browser, the web browser extension based upon the substantially unique identifier.
    Type: Grant
    Filed: September 27, 2011
    Date of Patent: June 12, 2012
    Assignee: Google Inc.
    Inventors: Aaron Boodman, Erik Kay, Rafael Weinstein, Matthew Perry, Antony Sargent
  • Patent number: 8176321
    Abstract: Methods and apparatus for installing browser extensions using sandboxed processes are disclosed. An example method includes receiving a browser extension installation package in a main browser process, placing the browser extension installation package in a temporary directory and launching a sandboxed sub-process of the browser application, where the sandboxed sub-process has access to the temporary directory. The example method includes, in the sandboxed sub-process: unpacking a compressed, archived file of the installation package into the plurality of constituent files of the browser extension and transcoding or recoding at least one of the plurality of constituent files, where the transcoded and recoded files replace their corresponding original constituent files. The example method includes, after the transcoding and/or recoding, passing the constituent files back to a main browser process and installing the browser extension to the browser application using the transcoded and recoded constituent files.
    Type: Grant
    Filed: September 27, 2011
    Date of Patent: May 8, 2012
    Assignee: Google Inc.
    Inventors: Matthew Perry, Aaron Boodman, Erik Kay, Antony John Sargent
  • Publication number: 20090253929
    Abstract: The present invention concerns a compound of formula (I): wherein R1 is C1-4 alkyl, or benzyl optionally substituted by halogen, C1-4alkyl (optionally substituted by halogen or C1-4 alkoxy), C1-4 alkoxy, C1-4 alkoxycarbonyl, nitro or cyano; and a process for preparing a compound of formula (I).
    Type: Application
    Filed: December 7, 2005
    Publication date: October 8, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Allison Noble, Matthew Perry
  • Publication number: 20090197914
    Abstract: The present invention provides a compound of a formula (I) wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: March 6, 2007
    Publication date: August 6, 2009
    Inventors: Peter Cage, Mark Furber, Matthew Perry, Brian Springthorpe
  • Publication number: 20090118513
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: January 15, 2009
    Publication date: May 7, 2009
    Applicant: AstraZeneca AB
    Inventors: Moya Caffrey, Christopher Luckhurst, Tobias Mochel, Matthew Perry, Brian Springthorpe
  • Patent number: 7517989
    Abstract: The present invention provides a compound of formula (I), wherein: Z is (A) OR (B) and wherein the remaining variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of achemokine (such as CCR3) or H1 mediated disease state.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: April 14, 2009
    Assignee: AstraZeneca AB
    Inventors: Christopher Luckhurst, Matthew Perry, Hitesh Sanganee, Brian Springthorpe
  • Publication number: 20090069325
    Abstract: The present invention relates to the compounds of formula (I): in which: and the remaining variables are defined herein. The present invention also relates to a process for preparing such compounds and use of such compounds in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: November 10, 2008
    Publication date: March 12, 2009
    Applicant: AstraZeneca AB
    Inventors: Christopher Luckhurst, Matthew Perry, Hitesh Sanganee, Brian Springthorpe
  • Patent number: 7495013
    Abstract: The present invention relates to compounds of formula (I): The variables recited in formula (I) are defined in the specification. The present invention also relates to processes of preparing compounds of formula (I) and uses of such compounds for treating a chemokine (e.g., CCR3) or H1 mediated disease state.
    Type: Grant
    Filed: March 30, 2004
    Date of Patent: February 24, 2009
    Assignee: AstraZeneca AB
    Inventors: Moya Caffrey, Christopher Luckhurst, Tobias Mochel, Matthew Perry, Brian Springthorpe
  • Publication number: 20090023733
    Abstract: The present invention provides a compound of a formula (I): [Chemical formula should be inserted here. Please see paper copy] wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: March 6, 2007
    Publication date: January 22, 2009
    Inventors: Peter Cage, Mark Furber, Christopher Luckhurst, Matthew Perry, Brian Springthorpe
  • Publication number: 20090012125
    Abstract: The present invention provides a compound of a formula (I): [Chemical formula should be inserted here. Please see paper copy] wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: March 6, 2007
    Publication date: January 8, 2009
    Inventors: Peter Cage, Mark Furber, Tobias Mochel, Matthew Perry, Brian Springthorpe
  • Publication number: 20080275084
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: May 24, 2006
    Publication date: November 6, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Matthew Perry, Brian Springthorpe
  • Publication number: 20080262037
    Abstract: The present invention provides a compound of a formula (I) wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: April 5, 2005
    Publication date: October 23, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Tobias Mochel, Matthew Perry, Brian Springthorpe
  • Publication number: 20080207688
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: July 19, 2006
    Publication date: August 28, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Talbir Austin, David O'Sullivan, Matthew Perry, Brian Springthorpe
  • Publication number: 20080200505
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
    Type: Application
    Filed: May 24, 2006
    Publication date: August 21, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Matthew Perry, Brian Springthorpe
  • Publication number: 20080103422
    Abstract: A compression treatment system is provided that detects the number of and type of garments connected thereto. The system includes a plurality of ports, valves connected thereto and a number of garments having one or more bladders. The bladders are in fluid communication with a fluid source in a pneumatic circuit, to provide compression therapy once a user confirms the number of and type of garments connected to the system for use by a patient. A single pressure sensor communicates with a plurality of detected bladders located in the one or more garments.
    Type: Application
    Filed: November 21, 2007
    Publication date: May 1, 2008
    Applicant: TYCO HEALTHCARE GROUP LP
    Inventors: Matthew Perry, Mark Vess, Scott Wudyka
  • Patent number: 7307090
    Abstract: The invention provides a compound of formula (I), wherein: T is C(O) or S(O)2; W is C(O) or S(O)2; X is CH2, O or NH; Y is CR5 or N; R1 is optionally substituted aryl or optionally substituted heterocyclyl; R2 is hydrogen or C1-6alkyl; R3 is hydrogen or optionally substituted C1-6alkyl; and R4 is alkyl, optionally substituted aryl, optionally substituted aralkyl or optionally substituted heterocyclyl; that are modulators of chemokine (especially CCR3) activity and are especially useful for treating asthma and/or rhinitis
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: December 11, 2007
    Assignee: AstraZeneca AB
    Inventors: Richard Evans, Matthew Perry, Brian Springthorpe
  • Publication number: 20070276141
    Abstract: The invention provides anhydrous and hydrated forms of sodium salt of N-[[4-(3,4-dichlorophenoxy)[1,4?-bipiperidin]-1?-yl]carbonyl]-4-methyl-benzenesulfonamide and crystalline forms of N-[[4-(3,4-dichlorophenoxy)[1,4?-bipiperidin]-1?-yl]carbonyl]-4-methyl-benzenesulfonamide; and such compounds are modulators of chemokine (especially CCR3) activity and are especially useful for treating asthma and/or rhinitis.
    Type: Application
    Filed: November 3, 2004
    Publication date: November 29, 2007
    Inventors: Howard Else, Richard Evans, Peter Morgan, Philip O'keefe, Matthew Perry, Phil Plumb, Mark Purdie, Brian Springthorpe, Gerald Steele
  • Patent number: 7265227
    Abstract: The invention provides compounds of formula (I) wherein: T is C(O) or S(O)2; W is C(O) or S(O)2; X is CH2, O or NH; Y is CR11 or N; n is 0, 1 or 2; m is 1 or, when Y is CR11 m is 0; R1 is optionally substituted aryl or optionally substituted heterocyclyl; R2, R3, R,4, R5, R6, R7 and R8 are, independently, hydrogen or C?1-6#191 alkyl; R9 is hydrogen or C1-C6 alkyl; R10 is alkyl, optionally substituted aryl, optionally substituted aralkyl or optionally substituted heterocyclyl; and R11 is hydrogen or C1-C6 allkyl; that are modulators of chemokine (especially CCR3) activity and are especially useful for treating asthma and/or rhinitis.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: September 4, 2007
    Assignee: AstraZeneca AB
    Inventors: Richard Evans, Matthew Perry, Brian Springthorpe